INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2022

Anemia prevalence in U.S. adults increased significantly from 5.71% in 2005 to 6.86% in 2018, while treatment rates showed no significant trend.

Data from individuals aged 20 or older in NHANES from 2005 to 2018 were analyzed to assess trends and demographic factors associated with anemia prevalence and treatment. General anemia prevalence increased significantly from 5.71% to 6.86% (P trend < .001), while the trend in treatment rate was not significant (p = .148). Significant factors associated with anemia included age 60 or older (OR: 2.15 vs. 20-39 years), male sex (OR: 0.47 vs. female), non-Hispanic White race (OR: 0.22 vs. non-Hispanic Black), higher education (OR: 0.80), higher poverty income ratio (OR: 0.60 for >=3.5 vs. <=1.3), and U.S. birthplace (OR: 0.88). Anemia treatment was significantly associated with older age (OR: 1.51), male sex (OR: 0.53), U.S. birthplace (OR: 1.88), and having health insurance (OR: 1.80).

Shows an association, not proof of cause and effect.

Study type
Repeated cross-sectional study
Who was studied
U.S. individuals aged 20 years or older from NHANES 2005 to 2018
What was measured
Anemia prevalence, anemia treatment rates, and demographic/socioeconomic correlates

THE PAPER

Trends in prevalence and treatment rate of anemia in the U.S. population: cross-sectional study using data from NHANES 2005-2018.

Wang C, Wang Y. Hematology, 2022.

PubMed 35962563 ↗DOI 10.1080/16078454.2022.2109557 ↗

Nutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.